Veli Kaan Aydin

Dr. Veli Kaan Aydin

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 December 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
VAVeli Kaan Aydin
Veli Kaan Aydin
YAYasemin ADALI
Yasemin ADALI
Aylin KöselerAylin Köseler
Aylin Köseler

22 May 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AOAlten Oskay
Alten Oskay
TOTulay Oskay
Tulay Oskay
VAVeli Kaan Aydin
Veli Kaan Aydin
ÖEÖzer Eser
Özer Eser
MSMurat Seyit
Murat Seyit
Aylin KöselerAylin Köseler
Aylin Köseler
Background/Objectives: Cytochrome P450 enzymes (CYP2D6, CYP2C19, CYP3A4) play a key role in interindividual variability in cardiovascular drug metabolism. This study aimed to describe metabolizer phenotype distributions in a Turkish emergency cardiac cohort and across diagnostic categories. Methods: This retrospective descriptive pharmacogenomic study included 250 patients. Genotyping was performed using TaqMan assays for CYP2D6 (*2, *4, *10, *41), CYP2C19 (*2, *17), and CYP3A4 (*22, *1B). Phenotypes were assigned according to CPIC guidelines. CYP2D6 copy-number variation was not assessed. Results: Non-normal metabolizer phenotypes were observed in 55.6% (CYP2D6), 84.4% (CYP2C19), and 30.4% (CYP3A4) of patients. For CYP2D6, normal (44.4%) and intermediate (42.0%) metabolizers predominated. For CYP2C19, intermediate metabolizers were most frequent (36.0%), followed by normal (22.8%), rapid (17.2%), poor (14.8%), and ultra-rapid metabolizers (9.2%). CYP3A4 showed predominantly normal activity (69.6%). Phenotype distributions varied across diagnoses without clear clustering. Conclusions: A high prevalence of CYP2D6 and CYP2C19 variability with predicted functional relevance based on CPIC was observed, whereas CYP3A4 activity was more stable. These findings provide descriptive pharmacogenomic data to support future genotype-guided cardiovascular therapy studies.

1 January 2025 in Emergency Medicine International
Verified
Journal Article
Open access
YAYasemin ADALI
Yasemin ADALI
ITIbrahim Türkçüer
Ibrahim Türkçüer
YBYasemin Berberoğlu
Yasemin Berberoğlu
VAVeli Kaan Aydin
Veli Kaan Aydin
AYAtakan Yılmaz
Atakan Yılmaz
Aylin KöselerAylin Köseler
Aylin Köseler
Objective: Electrical injuries present a diagnostic and management challenge due to their diverse clinical manifestations and potential complications. Although the current guidelines recommend cardiac monitoring in selected cases, the criteria for risk stratification remain limited. This study aimed to evaluate the epidemiological and clinical characteristics of patients with electrical injuries admitted to the emergency department over a 10‐year period. Methods: This retrospective study reviewed medical records of patients admitted to the Pamukkale University Hospital between 2014 and 2024 due to electrical injuries. Data collected included age, sex, time of injury, voltage level, current type and source, contact site, transthoracic current pathway, ECG findings, laboratory results (troponin T, CK‐MB, and potassium), work‐related status, and mortality. The primary outcomes were epidemiological characteristics, ECG abnormalities, and laboratory evidence of myocardial injury. Results: A total of 112 patients were identified; 91 (81%) patients were male, with a mean age of 31.8 years. High‐voltage injuries (> 1000 V) occurred in 10 patients, while low‐voltage injuries (< 1000 V) were seen in 80 (60.6%) patients. Work‐related injuries accounted for 14.3% of cases. One patient died due to trauma following high‐voltage exposure. Troponin T was elevated in 57 of 92 tested patients (62.0%), CK‐MB in 25 (22.3%), and hyperkalemia in six (5.3%). ECG abnormalities were detected in 16 patients (14.3%). Conclusion: Biochemical evidence of myocardial injury was observed even in low‐voltage exposures, raising concerns about the safety of early discharge based solely on clinical presentation and ECG findings. Prospective studies are needed to refine risk assessment strategies in electrical injury cases.

13 December 2025 in Journal of Bone Oncology
Verified
Journal Article
Open access
VAVeli Kaan Aydin
Veli Kaan Aydin
LSLubaid Saleh
Lubaid Saleh
POPenelope Dawn Ottewell
Penelope Dawn Ottewell
IHIngunn Holen
Ingunn Holen
Differential effects of doxorubicin (DOX) on bone and bone marrow cell populations in immunocompetent and immunocompromised mice

13 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
İKİLKER KİRAZ
İLKER KİRAZ
VAVeli Kaan Aydin
Veli Kaan Aydin
ÖZGÜR KURTÖZGÜR KURT
ÖZGÜR KURT
MCMehmet Erdal Coşkun
Mehmet Erdal Coşkun
GLGergana Lengerova
Gergana Lengerova
Aylin KöselerAylin Köseler
Aylin Köseler
Background: Temozolomide (TMZ) resistance represents a major therapeutic challenge in glioblastoma treatment, where autophagy has emerged as a key adaptive survival mechanism. Although numerous studies have implicated autophagy in TMZ resistance, most have assessed this process at a single point, thereby overlooking its dynamic and time-dependent nature. Methods: In this study, we systematically investigated the temporal regulation of autophagy-related gene expression in two human glioblastoma cell lines with distinct MGMT methylation status and TMZ sensitivities (T98G and U87) following TMZ treatment. Cells were exposed to TMZ and harvested at defined time points (0 h, 6 h, 24 h, and 48 h). The expression levels of genes representing distinct stages of the autophagy pathway, including initiation, nucleation, elongation, selective autophagy, lysosomal function, and transcriptional regulation, were analyzed using RT-qPCR. Relative gene expression was calculated using the 2−ΔΔCT method with GAPDH as the reference gene. Results: Our results reveal a time-dependent and phase-specific transcriptional reprogramming of the autophagy machinery in response to TMZ-induced stress. Early time points were characterized by modulation of autophagy initiation and nucleation genes, whereas intermediate and late phases showed prominent regulation of genes associated with autophagosome elongation, selective autophagy, autophagic flux, and transcriptional control. Conclusions: Collectively, these findings demonstrate that autophagy in TMZ-treated glioblastoma cells is not a static response but a dynamically regulated, multi-phase program. Specifically, in TMZ-resistant T98G cells, this process matures into a sustained adaptive program with robust late-phase lysosomal integration, while in TMZ-sensitive U87 cells, the early autophagic response is transient and fails to support long-term lysosomal coordination. This temporal perspective provides new insights into the role of autophagy in TMZ tolerance and underscores the importance of time-resolved analyses when targeting autophagy to overcome chemoresistance in glioblastoma.